Expression of Receptor Activator of Nuclear Factor κ-B Ligand (RANKL) in Neoplasms of Dogs and Cats

Abstract

In dogs and cats, tumors classically involving bone and causing pain, often may express RANKL. Confirming RANKL expression in tumors is a necessary step toward the rational institution of novel therapies targeting malignant osteolysis via RANKL antagonism.